Abstract 2022-RA-435-ESGO Table 1 Summary of patient data
No | Age | FIGO stage | Initial surgery/residual | PFI (month) | Prior chemo | PS | Acsites | SDS/residual | Washing cytology | Intraperitoneal relapse after SDS | Outcome | Follow up (month) |
---|
|
---|
1 | 74 | IVB | IDS/0 mm | 32 | no | 0 | no | 0 mm | negative | no | NED | 82 |
2 | 72 | IIIC | IDS/<10 mm | 6 | yes | 1 | no | <10 mm | positive | yes | DFD | 16 |
3 | 82 | IIIC | PDS/0 mm | 17 | no | 1 | no | 0 mm | positive | yes | DFD | 40 |
4 | 65 | IIIC | PDS/0 mm | 81 | yes | 0 | no | 0 mm | negative | no | NED | 20** |
5 | 66 | IC | PDS/0 mm | 60 | no | 0 | no | 0 mm | negative | no | LN meta/NED* | 89 |
6 | 69 | IIIC | PDS/<10 mm | 37 | yes | 0 | no | 0 mm | negative | no | NED* | 84 |
7 | 70 | IIIB | PDS/0 mm | 44 | no | 1 | no | 0 mm | positive | yes | DFD | 36 |
8 | 53 | IC | PDS/0 mm | 42 | yes | 0 | no | 0 mm | negative | no | NED | 108 |
9 | 73 | IIIC | IDS/0 mm | 27 | yes | 0 | no | 0 mm | negative | no | DFOD | 78 |
10 | 72 | IIIC | PDS/0 mm | 36 | yes | 0 | no | 0 mm | negative | no | Brain meta/DFD | 43 |
11 | 77 | IIC | PDS/0 mm | 63 | no | 0 | no | 0 mm | negative | no | DFOD | 58 |
12 | 57 | IIIC | IDS/0 mm | 27 | yes | 0 | no | 0 mm | positive | yes | DFD | 17 |
13 | 48 | IIIC | PDS/0 mm | 23 | yes | 0 | no | 0 mm | negative | no | NED | 44** |